Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eva Ersdal"'
Autor:
Cecilia Kristensson, Annika Åstrand, Scott Donaldson, Ron Goldwater, Raolat Abdulai, Naimish Patel, Philip Gardiner, Ulrika Tehler, Anne-Kristina Mercier, Marita Olsson, Eva Ersdal, Jukka Mäenpää, Tobias Bramer, Anna Malmgren, William Bennett, Christina Keen
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 21(4)
Epithelial sodium channel (ENaC) inhibitors may offer clinical benefit in cystic fibrosis (CF); however, data are limited. We report the outcomes of a Phase I (NCT02679729) and a Phase Ib (NCT02950805) study of AZD5634, a novel inhaled ENaC inhibitor
Autor:
Barry J. Make, Robert Palmér, Graham W. Clarke, Robert A. Wise, Stephen I. Rennard, Sara Asimus, Nisha Kurian, Tove Hegelund-Myrbäck, Katarina Korsback, Malin Fagerås, Danen Cunoosamy, Paul S. Jansson, Steven Greenaway, Cecilia Kristensson, Eva Ersdal, Katerina Pardali, Naimish Patel, Leonard Siew, Mary N. Brown, Ziad Taib, Sofia Lundin
Publikováno v:
International Journal of COPD, Vol Volume 13, Pp 1009-1019 (2018)
International Journal of Chronic Obstructive Pulmonary Disease
International Journal of Chronic Obstructive Pulmonary Disease
Naimish R Patel,1,2 Danen M Cunoosamy,1 Malin Fagerås,1 Ziad Taib,1 Sara Asimus,1 Tove Hegelund-Myrbäck,1 Sofia Lundin,1 Katerina Pardali,1 Nisha Kurian,1 Eva Ersdal,1 Cecilia Kristensson,1 Katarina Korsback,1 Robert Palmér,1 Mary N Brown,3 Steven
Publikováno v:
Biochemistry. 34:8433-8440
Two antithrombin III (ATIII) isoforms occur naturally in human plasma. The alpha-ATIII isoform has four N-linked oligosaccharides attached to asparagines 96, 135, 155, and 192. The beta-ATIII isoform lacks carbohydrate on asparagine-135 (N135), which
Publikováno v:
Clinical drug investigation. 25(7)
Objective: To assess the potential effects of food on the pharmacokinetics and tolerability/safety of ximelagatran, an oral direct thrombin inhibitor developed for the prevention and treatment of thromboembolic disease that is rapidly bioconverted to
Publikováno v:
The Journal of biological chemistry. 272(31)
The heparin binding site of the anticoagulant protein antithrombin III (ATIII) has been defined at high resolution by alanine scanning mutagenesis of 17 basic residues previously thought to interact with the cofactor based on chemical modification ex
Autor:
Eva Ersdal-Badju, Veronique Picard, Aiqin Lu, Steven T. Olson, Xiaoming Peng, Ingemar Björk, Susan Clark Bock, Boris Turk, P. Zendehrouh
In order to promote homogeneity of recombinant antithrombin III interactions with heparin, an asparagine-135 to alanine substitution mutant was expressed in baculovirus-infected insect cells. The N135A variant does not bear an N-linked oligosaccharid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e28fed5b50314864154cf2d86d040e3
https://europepmc.org/articles/PMC1135891/
https://europepmc.org/articles/PMC1135891/
Publikováno v:
Biochemistry. 25:3884-3890
The binding of human coagulation factor XI to washed human platelets was studied in the presence of zinc ions, calcium ions, and high molecular weight kininogen. Significant factor XI binding occurred at physiological levels of these metal ions when